"Copyright Accuser Faces Review Bombing Over Schedule I Claims"

In a surprising turn of events, indie game Schedule I has been accused of copyright infringement by Movie Games S.A., the creators of the The Drug Dealer Simulator series. According to a report by the Polish Press Agency dated April 3, Movie Games S.A. claims that Schedule I may have infringed on their intellectual property by copying the plot, mechanics, and user interface of The Drug Dealer Simulator. However, while the legal battle unfolds, fans have taken matters into their own hands, rallying behind Schedule I and review-bombing the accuser's games on Steam.

Schedule I Recent Updates

Schedule I’s Copyright Infringement Accuser Gets Review Bombed on Steam

The backlash against Movie Games S.A. has been significant, with The Drug Dealer Simulator and Drug Dealer Simulator 2 now bearing the brunt of negative reviews, earning ratings of "Overwhelmingly Negative" and "Mostly Negative" on Steam, respectively. Critics among the gaming community have accused Movie Games S.A. of bullying the indie developer behind Schedule I and highlighted the apparent hypocrisy, noting that similar titles were not targeted in the past.

Despite the controversy, Schedule I continues to thrive. Launched into Early Access on PC on March 25, this co-op crime simulation game has players start as a small-time dope pusher, aiming to rise to the top of the criminal world. It has garnered an "Overwhelmingly Positive" reception on Steam, where it stands as the 2nd top-selling game, surpassing titles like inZOI, Monster Hunter Wilds, and R.E.P.O.. The game's popularity is further evidenced by its all-time peak of 459,075 concurrent players, as reported by SteamDB.

Here at Game8, we found Schedule I to be a surprisingly engaging and rewarding experience, earning it the nickname of a "Breaking Bad" simulator. For more in-depth insights into our experience with Schedule I during its early access phase, feel free to explore our detailed review below!